Ginkgo Bioworks Holdings (DNA) Non Operating Investment Income (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Non Operating Investment Income readings, the most recent being -$16.2 million for Q4 2025.

  • On a quarterly basis, Non Operating Investment Income fell 28.92% to -$16.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$16.4 million, a 43.07% increase, with the full-year FY2025 number at -$16.4 million, up 43.07% from a year prior.
  • Non Operating Investment Income hit -$16.2 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $3.7 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $12.6 million in Q1 2021 to a low of -$38.7 million in Q2 2022.
  • Median Non Operating Investment Income over the past 5 years was -$6.6 million (2023), compared with a mean of -$8.2 million.
  • Biggest five-year swings in Non Operating Investment Income: plummeted 13642.22% in 2021 and later soared 153.3% in 2025.
  • Ginkgo Bioworks Holdings' Non Operating Investment Income stood at -$14.6 million in 2021, then rose by 8.23% to -$13.4 million in 2022, then increased by 25.03% to -$10.0 million in 2023, then fell by 25.3% to -$12.5 million in 2024, then fell by 28.92% to -$16.2 million in 2025.
  • The last three reported values for Non Operating Investment Income were -$16.2 million (Q4 2025), $3.7 million (Q3 2025), and -$229000.0 (Q2 2025) per Business Quant data.